These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27997854)

  • 1. The emerging metabolic view of Clostridium difficile pathogenesis.
    Hryckowian AJ; Pruss KM; Sonnenburg JL
    Curr Opin Microbiol; 2017 Feb; 35():42-47. PubMed ID: 27997854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
    Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
    Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile.
    Britton RA; Young VB
    Gastroenterology; 2014 May; 146(6):1547-53. PubMed ID: 24503131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota.
    Fletcher JR; Pike CM; Parsons RJ; Rivera AJ; Foley MH; McLaren MR; Montgomery SA; Theriot CM
    Nat Commun; 2021 Jan; 12(1):462. PubMed ID: 33469019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
    Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
    mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile infection.
    Smits WK; Lyras D; Lacy DB; Wilcox MH; Kuijper EJ
    Nat Rev Dis Primers; 2016 Apr; 2():16020. PubMed ID: 27158839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
    Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
    mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbe-microbe interactions during Clostridioides difficile infection.
    Abbas A; Zackular JP
    Curr Opin Microbiol; 2020 Feb; 53():19-25. PubMed ID: 32088581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
    Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
    mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.
    Sun X; Hirota SA
    Mol Immunol; 2015 Feb; 63(2):193-202. PubMed ID: 25242213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent insights into Clostridium difficile pathogenesis.
    Peniche AG; Savidge TC; Dann SM
    Curr Opin Infect Dis; 2013 Oct; 26(5):447-53. PubMed ID: 23982235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of gut fungi in Clostridioides difficile infection.
    Wang L; Cao Y; Lou E; Zhao X; Chen X
    Biomed J; 2024 Jun; 47(3):100686. PubMed ID: 38086471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
    Lesniak NA; Schubert AM; Sinani H; Schloss PD
    mSphere; 2021 May; 6(3):. PubMed ID: 33952668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating gut microbiome and host immune markers to understand the pathogenesis of
    Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
    [No Abstract]   [Full Text] [Related]  

  • 15. Bile acids impact the microbiota, host, and
    McMillan AS; Theriot CM
    Gut Microbes; 2024; 16(1):2393766. PubMed ID: 39224076
    [No Abstract]   [Full Text] [Related]  

  • 16. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.
    Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C
    mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
    Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
    J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of toxins in Clostridium difficile infection.
    Chandrasekaran R; Lacy DB
    FEMS Microbiol Rev; 2017 Nov; 41(6):723-750. PubMed ID: 29048477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
    Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
    mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridioides difficile Infections: Prevention and Treatment Strategies.
    Levy EI; Dinleyici M; Dinleyici E; Vandenplas Y
    Adv Exp Med Biol; 2024; 1449():175-186. PubMed ID: 39060738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.